Relmada Therapeutics, Inc. (RLMD) stock
RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.01−0.60 (-16.62%)
Close on Nov 17, 2026Market cap $321.08MP/E –Yield –
Relmada Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Relmada Therapeutics's market cap was $472.55M on Nov 11, 2026, against $149.69M a year earlier. Over the last 5 years it ranged from $5.07M to $1.09B, with a median of $109.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $472.55M | +194.8% |
| 2025 | Dec 31, 2025 | $160.32M | +921.7% |
| 2024 | Dec 31, 2024 | $15.69M | -87.4% |
| 2023 | Dec 29, 2023 | $124.61M | +2359.0% |
| 2022 | Dec 30, 2022 | $5.07M | -98.7% |
| 2021 | Dec 31, 2021 | $394.31M | +26.2% |
| 2020 | Dec 31, 2020 | $312.51M | -17.8% |
| 2019 | Dec 31, 2019 | $380.04M | +2533.3% |
| 2018 | Dec 31, 2018 | $14.43M | +53.4% |
| 2017 | Dec 29, 2017 | $9.41M | -28.3% |
| 2016 | Dec 30, 2016 | $13.12M | -52.4% |
| 2015 | Dec 31, 2015 | $27.54M | +79.1% |
| 2014 | Dec 31, 2014 | $15.37M | – |
See a number that looks wrong?